Published in Proc Eur Dial Transplant Assoc Eur Ren Assoc on January 01, 1985
Erythropoiesis-stimulating agents and other methods to enhance oxygen transport. Br J Pharmacol (2008) 0.96
Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet (1993) 6.56
Fibrate-induced increase in blood urea and creatinine: is gemfibrozil the only innocuous agent? Nephrol Dial Transplant (2000) 2.99
Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries. Nephrol Dial Transplant (2001) 1.87
High concentrations of N-BNP are related to non-infectious severe SIRS associated with cardiovascular dysfunction occurring after off-pump coronary artery surgery. Br J Anaesth (2004) 1.75
The chemical composition of idiopathic nonarteriosclerotic cerebral calcifications. Neurology (1975) 1.59
Prone positioning during veno-venous extracorporeal membrane oxygenation for severe acute respiratory distress syndrome in adults. Minerva Anestesiol (2013) 1.56
Clinical characteristics and outcome of infective endocarditis in adults with bicuspid aortic valves: a multicentre observational study. Heart (2010) 1.52
Contribution of systematic serological testing in diagnosis of infective endocarditis. J Clin Microbiol (2005) 1.50
Flavobacterium multivorum septicemia in a hemodialyzed patient. J Clin Microbiol (1984) 1.49
Comparison of cellulose diacetate and polysulfone membranes in the outcome of acute renal failure. A prospective randomized study. Nephrol Dial Transplant (2000) 1.46
The neurotoxicity and safety of treatment with cefepime in patients with renal failure. Nephrol Dial Transplant (2008) 1.46
The predictive value of cardiac troponin T measurements in subjects on regular haemodialysis. Nephrol Dial Transplant (1999) 1.43
High haematocrit in haemodialysis patients can be controlled by theophylline administration. Nephrol Dial Transplant (1994) 1.40
Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: costs and reimbursement/funding of ESRD therapies. Nephrol Dial Transplant (1999) 1.39
Responsiveness to recombinant erythropoietin therapy in end-stage renal disease. An analysis of the predictive value of several biological measurements, including circulating erythroid progenitors. Nephrol Dial Transplant (1992) 1.38
A previously undescribed side effect of icodextrin: overestimation of glycemia by glucose analyzer. Perit Dial Int (1999) 1.32
Aristolochic acid induces proximal tubule apoptosis and epithelial to mesenchymal transformation. Kidney Int (2007) 1.19
Guidance for robustness/ruggedness tests in method validation. J Pharm Biomed Anal (2001) 1.14
Validation of bioanalytical chromatographic methods. J Pharm Biomed Anal (1998) 1.13
Crystal structures of delta1-pyrroline-5-carboxylate reductase from human pathogens Neisseria meningitides and Streptococcus pyogenes. J Mol Biol (2005) 1.08
Structure of Bacillus subtilis YXKO--a member of the UPF0031 family and a putative kinase. J Struct Biol (2002) 1.05
A protein complex expressed during terminal differentiation of monomyelocytic cells is an inhibitor of cell growth. Cell Growth Differ (1990) 1.05
Survival in dialysis patients is different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition. Diabetologia (2013) 1.04
Pseudomonas paucimobilis peritonitis in patients treated by peritoneal dialysis. J Clin Microbiol (1984) 1.04
Crystal structure of Bacillus subtilis ioli shows endonuclase IV fold with altered Zn binding. Proteins (2002) 1.02
Morphological, structural and chemical study of small calcifications. Acta Neurol Belg (1974) 1.01
Crystal structure of aminopeptidase N from human pathogen Neisseria meningitidis. Proteins (2008) 0.99
Quantification of renal perfusion and function on a voxel-by-voxel basis: a feasibility study. Magn Reson Med (2005) 0.98
Altered antioxidant defence in a mouse adriamycin model of glomerulosclerosis. Nephrol Dial Transplant (2001) 0.98
Chromatographic fingerprint development for herbal extracts: a screening and optimization methodology on monolithic columns. J Chromatogr A (2007) 0.96
Unwinding of supercoiled DNA by cis- and trans-diamminedichloroplatinum(II): influence of the torsional strain on DNA unwinding. Nucleic Acids Res (1985) 0.93
Exploratory analysis of chromatographic fingerprints to distinguish rhizoma Chuanxiong and rhizoma Ligustici. J Chromatogr A (2010) 0.92
Long-term results of subcutaneous parathyroid grafts in uremic patients. Arch Surg (2000) 0.91
Intra-individual comparison of captopril and enalapril in patients undergoing regular haemodialysis. Eur J Clin Pharmacol (1986) 0.89
Autotracing of Escherichia coli acetate CoA-transferase alpha-subunit structure using 3.4 A MAD and 1.9 A native data. Acta Crystallogr D Biol Crystallogr (2002) 0.89
Effect of vasopressin on the isolated human collecting duct. Nature (1974) 0.89
Chinese herbs nephropathy and renal pelvic carcinoma. Nephrol Dial Transplant (1995) 0.88
Role of complement and platelet-activating factor in the stimulation of phagocytosis and reactive oxygen species production during haemodialysis. Nephrol Dial Transplant (2000) 0.87
Similarity analyses of chromatographic fingerprints as tools for identification and quality control of green tea. J Chromatogr B Analyt Technol Biomed Life Sci (2012) 0.86
Effects of steroids on the progression of renal failure in chronic interstitial renal fibrosis: a pilot study in Chinese herbs nephropathy. Am J Kidney Dis (1996) 0.86
Intraperitoneal fluconazole therapy for Trichosporon cutaneum peritonitis in continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant (1994) 0.86
Campylobacter fetus peritonitis followed by septicaemia in a patient on continuous ambulatory peritoneal dialysis. J Infect (1985) 0.86
Legionnaires' disease and acute renal insufficiency: report of a case and review of the literature. Acta Clin Belg (1995) 0.85
Renal biopsy findings in Belgium: a retrospective single center analysis. Acta Clin Belg (2011) 0.85
The referral pattern of patients with ESRD is a determinant in the choice of dialysis modality. Perit Dial Int (1997) 0.84
[Perioperative management of ventricular assist devices]. Ann Fr Anesth Reanim (2003) 0.84
Lipid and apoprotein changes during atorvastatin up-titration in hemodialysis patients with hypercholesterolemia: a placebo-controlled study. Clin Nephrol (2004) 0.84
Increased plasma levels of pro-brain natriuretic peptide in patients with cardiovascular complications following off-pump coronary artery surgery. Intensive Care Med (2004) 0.83
Intramembranous particle aggregation in toad urinary bladder after vasopressin stimulation. Lab Invest (1979) 0.83
Pharmacokinetics of vancomycin in patients undergoing haemodialysis and haemofiltration. Nephrol Dial Transplant (1989) 0.83
Reversible membranous glomerulonephritis associated with ketoprofen. Clin Nephrol (1986) 0.82
Measurement uncertainty from validation and duplicate analysis results in HPLC analysis of multivitamin preparations and nutrients with different galenic forms. J Pharm Biomed Anal (2003) 0.82
Chemometric treatment of vanillin fingerprint chromatograms. Effect of different signal alignments on principal component analysis plots. J Chromatogr A (2005) 0.82
Resistance to erythropoietin in iron-overloaded haemodialysis patients can be overcome by ascorbic acid administration. Nephrol Dial Transplant (1995) 0.82
The pharmacokinetics of perindopril and its effects on serum angiotensin converting enzyme activity in hypertensive patients with chronic renal failure. Br J Clin Pharmacol (1992) 0.82
Multiple transfusions and T cell subsets: a role for ferritin? Transplantation (1983) 0.82
Impaired humoral and cell-mediated immune responses in dialyzed patients after influenza vaccination. Nephron (1983) 0.82
Acute tubulo-interstitial nephritis and renal infarction secondary to ergotamine therapy. Nephrol Dial Transplant (2000) 0.81
Osteoprotegerin and progression of coronary and aortic calcifications in chronic kidney disease. Transplant Proc (2010) 0.81
Severe acute pancreatitis associated with peliosis hepatis in a patient with systemic lupus erythematosus. Acta Gastroenterol Belg (2001) 0.81
Hemodynamics of patients with renal failure treated with recombinant human erythropoietin. Clin Nephrol (1989) 0.81
Non-linear mixed effects models for the evaluation of dissolution profiles. Int J Pharm (2002) 0.81
Pamidronate-related nephrotoxicity (tubulointerstitial nephritis) in a patient with osteolytic bone metastases. Nephron (2001) 0.80
Hypercalcaemia induced by oestrogen withdrawal in vitamin D-treated hypoparathyroidism. Br Med J (1979) 0.80
Chromosomal localization and structure of the human type II IMP dehydrogenase gene (IMPDH2). Genomics (1993) 0.80
Model for assessment of lead content in human surface enamel. J Toxicol Environ Health (1991) 0.80
Group JK corynebacterium peritonitis in a patient undergoing continuous ambulatory peritoneal dialysis. J Clin Microbiol (1983) 0.80
Critical role of iron overload in the increased susceptibility of haemodialysis patients to bacterial infections. Beneficial effects of desferrioxamine. Nephrol Dial Transplant (1989) 0.80
Evaluation of surgical treatment of renal hyperparathyroidism by measuring intact parathormone blood levels on first postoperative day. World J Surg (1998) 0.80
Cuprophane haemodialysis induces upregulation of LPS receptor (CD14) on monocytes: role of complement activation. Nephrol Dial Transplant (1996) 0.80
Continuous hemofiltration in severe sepsis: is it beneficial? J Crit Care (1995) 0.80
Perioperative cerebral ischaemia in cardiac surgery and BIS. Anaesth Intensive Care (2005) 0.80
Effect of treatment with 1.25 and 1.75 mmol/l calcium dialysate on bone mineral density in haemodialysis patients. Nephrol Dial Transplant (1995) 0.79
Quantitative ultrasound and dual X-ray absorptiometry measurements of the calcaneus in patients on maintenance hemodialysis. Bone (2000) 0.79
Renal antioxidant enzymes and fibrosis-related markers in the rat adriamycin model. Nephron (2000) 0.79
Application of linear mixed effects models to the evaluation of dissolution profiles. Int J Pharm (2001) 0.79
Crystal structure of Bacillus subtilis YckF: structural and functional evolution. J Struct Biol (2004) 0.79
Malignant Mediterranean spotted fever. Report of a case with multiple organ failure, hypocalcemia, and euthyroid sick syndrome. Arch Intern Med (1985) 0.79
Evaluation of dissolution profiles using principal component analysis. Int J Pharm (2001) 0.79
Development and validation of a normal-phase HPTLC method for the simultaneous analysis of lamivudine, stavudine and nevirapine in fixed-dose combination tablets. J Pharm Biomed Anal (2010) 0.79
Paraquat poisoning and colchicine treatment. Ann Intern Med (1981) 0.79
Pharmacokinetics of linsidomine (SIN 1) after single and multiple intravenous short infusions in patients with renal insufficiency. Int J Clin Pharmacol Ther Toxicol (1993) 0.79
Structure of phage protein BC1872 from Bacillus cereus, a singleton with new fold. Proteins (2006) 0.79
Schönlein-Henoch glomerulonephritis complicating diabetic glomerulosclerosis. Nephrol Dial Transplant (1995) 0.79
[Cardiac tumors]. Rev Pneumol Clin (2010) 0.78